Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and Myocardial Ischemia

1-(carboxymethylthio)tetradecane has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aasum, E; Berge, RK; Clarke, K; Hafstad, AD; Hagve, M; Khalid, AM; Larsen, TS; Lund, T; Severson, DL1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Myocardial Ischemia

ArticleYear
Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Cardiovascular research, 2009, Aug-01, Volume: 83, Issue:3

    Topics: Administration, Oral; Animals; Blood Glucose; Cardiovascular Agents; Disease Models, Animal; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidation-Reduction; Oxygen Consumption; PPAR alpha; Recovery of Function; RNA, Messenger; Sulfides; Triglycerides; Ventricular Function

2009